GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Oxygenta Pharmaceutical Ltd (BOM:524636) » Definitions » Cyclically Adjusted PS Ratio

Oxygenta Pharmaceutical (BOM:524636) Cyclically Adjusted PS Ratio : 1.46 (As of Jun. 23, 2024)


View and export this data going back to 1994. Start your Free Trial

What is Oxygenta Pharmaceutical Cyclically Adjusted PS Ratio?

As of today (2024-06-23), Oxygenta Pharmaceutical's current share price is ₹36.00. Oxygenta Pharmaceutical's Cyclically Adjusted Revenue per Share for the quarter that ended in Mar. 2024 was ₹24.63. Oxygenta Pharmaceutical's Cyclically Adjusted PS Ratio for today is 1.46.

The historical rank and industry rank for Oxygenta Pharmaceutical's Cyclically Adjusted PS Ratio or its related term are showing as below:

BOM:524636' s Cyclically Adjusted PS Ratio Range Over the Past 10 Years
Min: 1.02   Med: 1.36   Max: 1.94
Current: 1.48

During the past years, Oxygenta Pharmaceutical's highest Cyclically Adjusted PS Ratio was 1.94. The lowest was 1.02. And the median was 1.36.

BOM:524636's Cyclically Adjusted PS Ratio is ranked better than
62.45% of 743 companies
in the Drug Manufacturers industry
Industry Median: 2.06 vs BOM:524636: 1.48

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted revenue per share of a company over the past 10 years.

Oxygenta Pharmaceutical's adjusted revenue per share data for the three months ended in Mar. 2024 was ₹3.195. Add all the adjusted revenue per share for the past 10 years together and divide 10 will get our Cyclically Adjusted Revenue per Share, which is ₹24.63 for the trailing ten years ended in Mar. 2024.

Shiller PE for Stocks: The True Measure of Stock Valuation


Oxygenta Pharmaceutical Cyclically Adjusted PS Ratio Historical Data

The historical data trend for Oxygenta Pharmaceutical's Cyclically Adjusted PS Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Oxygenta Pharmaceutical Cyclically Adjusted PS Ratio Chart

Oxygenta Pharmaceutical Annual Data
Trend Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24
Cyclically Adjusted PS Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - 1.18

Oxygenta Pharmaceutical Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Cyclically Adjusted PS Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - 1.87 1.32 1.25 1.18

Competitive Comparison of Oxygenta Pharmaceutical's Cyclically Adjusted PS Ratio

For the Drug Manufacturers - Specialty & Generic subindustry, Oxygenta Pharmaceutical's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Oxygenta Pharmaceutical's Cyclically Adjusted PS Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Oxygenta Pharmaceutical's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where Oxygenta Pharmaceutical's Cyclically Adjusted PS Ratio falls into.



Oxygenta Pharmaceutical Cyclically Adjusted PS Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PS Ratio takes the Revenue per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/S calculation. Because it considers this 10-year average, it's often referred to as the CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio.

Oxygenta Pharmaceutical's Cyclically Adjusted PS Ratio for today is calculated as

Cyclically Adjusted PS Ratio=Share Price/ Cyclically Adjusted Revenue per Share
=36.00/24.63
=1.46

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Oxygenta Pharmaceutical's Cyclically Adjusted Revenue per Share for the quarter that ended in Mar. 2024 is calculated as:

For example, Oxygenta Pharmaceutical's adjusted Revenue per Share data for the three months ended in Mar. 2024 was:

Adj_RevenuePerShare=Revenue per Share/CPI of Mar. 2024 (Change)*Current CPI (Mar. 2024)
=3.195/153.0345*153.0345
=3.195

Current CPI (Mar. 2024) = 153.0345.

Oxygenta Pharmaceutical Quarterly Data

Revenue per Share CPI Adj_RevenuePerShare
201406 0.000 94.103 0.000
201409 0.302 96.780 0.478
201412 1.038 96.780 1.641
201503 0.635 97.163 1.000
201506 0.083 99.841 0.127
201509 0.636 101.753 0.957
201512 5.095 102.901 7.577
201603 2.964 102.518 4.425
201606 2.028 105.961 2.929
201609 1.110 105.961 1.603
201612 3.076 105.196 4.475
201703 1.765 105.196 2.568
201706 2.052 107.109 2.932
201709 2.256 109.021 3.167
201712 2.878 109.404 4.026
201803 5.420 109.786 7.555
201806 8.970 111.317 12.332
201809 5.899 115.142 7.840
201812 2.977 115.142 3.957
201903 3.690 118.202 4.777
201906 3.484 120.880 4.411
201909 3.964 123.175 4.925
201912 3.842 126.235 4.658
202003 2.146 124.705 2.634
202006 3.255 127.000 3.922
202009 8.217 130.118 9.664
202012 28.547 130.889 33.377
202103 10.871 131.771 12.625
202106 21.391 134.084 24.414
202109 11.002 135.847 12.394
202112 10.962 138.161 12.142
202203 4.982 138.822 5.492
202206 6.247 142.347 6.716
202209 4.252 144.661 4.498
202212 5.532 145.763 5.808
202303 5.758 146.865 6.000
202306 2.484 150.280 2.530
202309 3.600 151.492 3.637
202312 2.700 152.924 2.702
202403 3.195 153.035 3.195

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Oxygenta Pharmaceutical  (BOM:524636) Cyclically Adjusted PS Ratio Explanation

Compared with the regular PS Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PS Ratio smoothed out the fluctuations of revenue during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PS Ratio should give similar results to regular PS Ratio.


Oxygenta Pharmaceutical Cyclically Adjusted PS Ratio Related Terms

Thank you for viewing the detailed overview of Oxygenta Pharmaceutical's Cyclically Adjusted PS Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Oxygenta Pharmaceutical (BOM:524636) Business Description

Traded in Other Exchanges
N/A
Address
Plot no: 43, The Park View 1st Floor, Beside Sky View Suites (Saketa Nilayam), Behind Preston Prime Mall, Lumbini Avenue, Gachibowli, Hyderabad, TG, IND, 500032
Oxygenta Pharmaceutical Ltd is a pharmaceutical company. It is engaged in the business activity of manufacturing bulk drugs and API. It specializes in manufacturing anti ulcerative and anti-bacterial drugs. The Company has one reportable segment which is Pharmaceutical. The group carries its business operations within India.

Oxygenta Pharmaceutical (BOM:524636) Headlines

No Headlines